Evidence for breast cancer as an integral part of lynch syndrome

Genes Chromosomes and Cancer

Volumn 51, Issue 1, 2012, Pages 83-91

  Buerki, Nicole ^a,b,c   Gautier, Lucienne ^b,c   Kovac, Michal ^b,c   Marra, Giancarlo ^d   Buser, Mauro ^b   Mueller, Hansjakob ^b,c   Heinimann, Karl ^b,c  

^a Kantonsspital Liestal   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2;

ADULT; AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER INCIDENCE; COLORECTAL CANCER; ENDOMETRIUM CANCER; FEMALE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; BREAST NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; FEMALE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; INCIDENCE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASMS; NUCLEAR PROTEINS;

EID: 80455156386     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20935     Document Type: Article

References (41)

1. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. 1995. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64: 430-433.
2. Aarnio M, Salovaara R, Aaltonen LA, Mecklin JP, Jarvinen HJ. 1997. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer 74: 551-555.
3. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltomaki P, Mecklin JP, Jarvinen HJ. 1999. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81: 214-218.
4. Adem C, Soderberg CL, Cunningham JM, Reynolds C, Sebo TJ, Thibodeau SN, Hartmann LC, Jenkins RB. 2003. Microsatellite instability in hereditary and sporadic breast cancers. Int J Cancer 107: 580-582.
5. ASRT, VSKR. 2007. Cancer in Switzerland: Statistics of incidence and mortality based on data from 1986-2005. Accessed December 12, 2007, URL address: Swiss Association of Cancer Registries, hosted by the international union against cancer (UICC).
6. Barrow E, Robinson L, Alduaij W, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG. 2009. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clinical Genetics 75: 141-149.
7. Beiner ME, Rosen B, Fyles A, Harley I, Pal T, Siminovitch K, Zhang S, Sun P, Narod SA. 2006. Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2. Cancer Epidemiol Biomarkers Prev 15: 1636-1640.
8. Berends MJ, Wu Y, Sijmons RH, Mensink RG, van der Sluis T, Hordijk-Hos JM, de Vries EG, Hollema H, Karrenbeld A, Buys CH, van der Zee AG, Hofstra RM, Kleibeuker JH. 2002. Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet 70: 26-37.
9. Blokhuis M, Goldberg P, Pietersen G, Algar U, Vorster A, Govender D, Ramesar R. 2008. The extracolonic cancer spectrum in females with the common 'South African' hMLH1 c.C1528T mutation. Familial Cancer 7: 191-198.
10. Burki N, Gencik A, Torhorst JK, Weber W, Muller H. 1987. Familial and histological analyses of 138 breast cancer patients. Breast Cancer Res Treat 10: 159-167.
11. de Leeuw WJ, van Puijenbroek M, Tollenaar RA, Cornelisse CJ, Vasen HF, Morreau H. 2003. Correspondence re: Muller A, Edmonston TB, Corao DA, Rose DG, Palazzo JP, Becker H, Fry RD, Rueschoff J, Fishel R. Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res 62: 1014-1019, 2002; Cancer Res 63: 1148-1149.
12. Elandt-Johnson RC, Johnson NL. 1980. Survival Models and Data Analysis. New York: Wiley.
13. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush AJ, Berk T, Cohen Z, Tetu B, Burger PC, Wood PA, Taqi F, Booker SV, Petersen GM, Offerhaus GJA, Tersmette AC, Giardiello FM, Vogelstein B, Kinzler KW. 1995. The molecular basis of Turcot's syndrome. N Engl J Med 332: 839-847.
14. Heinimann K, Muller H, Weber W, Scott RJ. 1997. Disease expression in Swiss hereditary non-polyposis colorectal cancer (HNPCC) kindreds. Int J Cancer 74: 281-285.
15. Hollander, Myles, Wolfe, Douglas A. 1973. Nonparametric Statistical Methods. New York: John Wiley & Sons.
16. Kuligina E, Grigoriev MY, Suspitsin EN, Buslov KG, Zaitseva OA, Yatsuk OS, Lazareva YR, Togo AV, Imyanitov EN. 2007. Microsatellite instability analysis of bilateral breast tumors suggests treatment-related origin of some contralateral malignancies. J Cancer Res Clin Oncol 133: 57-64.
17. Lin KM, Shashidharan M, Thorson AG, Ternent CA, Blatchford GJ, Christensen MA, Watson P, Lemon SJ, Franklin B, Karr B, Lynch J, Lynch HT. 1998. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J Gastrointest Surg 2: 67-71.
18. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, Jass JR, Dunlop M, Wyllie A, Peltomaki P, de la Chapelle A, Hamilton SR, Vogelstein B, Kinzler KW. 1996. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2: 169-174.
19. Lynch HT, Smyrk T. 1996. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 78: 1149-1167.
20. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, Cavalieri RJ, Boland CR. 1993. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104: 1535-1549.
21. Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR. 2009. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76: 1-18.
22. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
23. Muller A, Edmonston TB, Corao DA, Rose DG, Palazzo JP, Becker H, Fry RD, Rueschoff J, Fishel R. 2002. Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res 62: 1014-1019.
24. Oliveira Ferreira F, Napoli Ferreira CC, Rossi BM, Toshihiko Nakagawa W, Aguilar S, Jr., Monteiro Santos EM, Vierira Costa ML, Lopes A. 2004. Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry. Fam Cancer 3: 41-47.
25. Risinger JI, Barrett JC, Watson P, Lynch HT, Boyd J. 1996. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 77: 1836-1843.
26. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S. 1997. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89: 1758-1762.
27. Rodriguez-Bigas MA, Vasen HF, Lynch HT, Watson P, Myrhoj T, Jarvinen HJ, Mecklin JP, Macrae F, St John DJ, Bertario L, Fidalgo P, Madlensky L, Rozen P. 1998. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer 83: 240-244.
28. Salovaara R, Loukola A, Kristo P, Kaariainen H, Ahtola H, Eskelinen M, Harkonen N, Julkunen R, Kangas E, Ojala S, Tulikoura J, Valkamo E, Jarvinen H, Mecklin JP, Aaltonen LA, de la Chapelle A. 2000. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 18: 2193-2200.
29. Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, du Sart D, Tucker K, Kirk J. 2001. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 68: 118-127.
30. Shanley S, Fung C, Milliken J, Leary J, Barnetson R, Schnitzler M, Kirk J. 2009. Breast cancer immunohistochemistry can be useful in triage of some HNPCC families. Fam Cancer.
31. Truninger K, Menigatti M, Luz J, Russell A, Haider R, Gebbers JO, Bannwart F, Yurtsever H, Neuweiler J, Riehle HM, Cattaruzza MS, Heinimann K, Schar P, Jiricny J, Marra G. 2005. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology 128: 1160-1171.
32. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S. 2004. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96: 261-268.
33. Vasen HF, Mecklin JP, Khan PM, Lynch HT. 1991. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34: 424-425.
34. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, Meijers-Heijboer EH, Bertario L, Varesco L, Bisgaard ML, Mohr J, Fodde R, Khan PM. 1996. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110: 1020-1027.
35. Vasen HF, Watson P, Mecklin JP, Lynch HT. 1999. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116: 1453-1456.
36. Vasen HF, Morreau H, Nortier JW. 2001. Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 68: 1533-1535.
37. Watson P, Riley B. 2005. The tumor spectrum in the Lynch syndrome. Fam Cancer 4: 245-248.
38. Watson P, Vasen HF, Mecklin JP, Jarvinen H, Lynch HT. 1994. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med 96: 516-520.
39. Watson P, Butzow R, Lynch HT, Mecklin JP, Jarvinen HJ, Vasen HF, Madlensky L, Fidalgo P, Bernstein I. 2001. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 82: 223-228.
40. Westenend PJ, Schutte R, Hoogmans MM, Wagner A, Dinjens WN. 2005. Breast cancer in an MSH2 gene mutation carrier. Hum Pathol 36: 1322-1326.
41. Zar, Jerold 1984. Biostatistical Analysis, 2nd ed. Englewood Cliffs, New Jersey: Prentics-Hall.